All immediate challenges to the status of abortifacient mifepristone on the US market are on ice for the near future after the Supreme Court on Apr. 21 — without...

At the beginning of 2023, the US Food and Drug Administration (FDA) stepped into a political hornet’s nest with its decision to allow retail pharmacies to dispense...